Kisspeptin
Also known as: Kisspeptin-10, Kisspeptin-54, Metastin
Primary recreational use: Sexual function enhancement
What is Kisspeptin?
Kisspeptin is a neuropeptide encoded by the KISS1 gene, acting as a critical regulator of the reproductive hormone axis. It's being explored for its potential in fertility treatments and reproductive disorders. Although not FDA approved, it is currently under investigation in clinical trials. While generally well-tolerated, long-term hormonal effects remain unknown.
Primary Benefits
Restores reproductive hormone function. Enhances fertility. Improves sexual function.
How It Works
Kisspeptin binds to the KISS1R receptor in the hypothalamus, stimulating the release of GnRH which subsequently triggers the secretion of LH and FSH. This pathway is crucial for the regulation of reproductive hormones such as testosterone and estrogen.
Safety Tips
Precautions reported in community discussions and literature. This is not a complete list.
- 1.DON'T start with high doses; begin conservatively to assess tolerance.
- 2.DON'T use kisspeptin daily to avoid receptor desensitization.
- 3.DON'T use without consulting a healthcare provider concerning fertility treatments.
- 4.AVOID if pregnant or breastfeeding due to potential hormonal effects.
- 5.ENSURE sterile injection technique to prevent infection.
Use Contexts
Different purposes have different protocols, dosing, and considerations
Fertility support
moderate evidenceUsed to enhance fertility by restoring reproductive hormone function, particularly in cases of hypogonadotropic hypogonadism.
Evidence: Studied in various human trials for its ability to induce gonadal steroid production.
The following are ranges reported in published literature and community discussions. These are NOT recommendations or medical advice.
Timing: Morning
Notes: Follow specific protocols supervised by a healthcare provider for fertility applications.
Community-Reported Protocols
Not recommendations: The following protocols are compiled from online communities and published literature. Pepbase does not endorse, recommend, or verify these protocols. They are provided for informational purposes only. Individual responses vary significantly. Consult a licensed medical professional before any use.
| Reported Goal | Reported Dose | Reported Frequency | Reported Route |
|---|---|---|---|
| Fertility support | 0.4-1.0 nmol/kg | As directed by physician | Subcutaneous (KP-54) |
Pharmacokinetics
Reported Side Effects
This is not a complete list. Other side effects may occur.
Common
Serious / Rare
- Cardiovascular effects
Injection-Specific Warnings
- Use sterile injection technique to prevent infection
Storage
Sexual enhancement
anecdotal evidenceUsed to improve sexual function and libido, particularly in cases of hypoactive sexual desire disorder.
Evidence: Community reports indicate improvements in sexual arousal networks.
The following are ranges reported in published literature and community discussions. These are NOT recommendations or medical advice.
Timing: Morning
Notes: Cycle with breaks to avoid desensitization.
Community-Reported Protocols
Not recommendations: The following protocols are compiled from online communities and published literature. Pepbase does not endorse, recommend, or verify these protocols. They are provided for informational purposes only. Individual responses vary significantly. Consult a licensed medical professional before any use.
| Reported Goal | Reported Dose | Reported Frequency | Reported Route |
|---|---|---|---|
| Sexual function | 1 nmol/kg/h | 75 min IV infusion (clinical) | IV infusion |
Pharmacokinetics
Reported Side Effects
This is not a complete list. Other side effects may occur.
Common
Storage
Harm Reduction Information
Quality Concerns
- Purity and authenticity issues if sourced non-clinically
Safety Tips
- Use sterile water for injection
- Store solution as recommended to avoid degradation
- Rotate injection sites to prevent tissue damage
Warning Signs to Stop
- New or worsening headaches
- Consistent nausea or gastrointestinal upset
Seek Medical Help Immediately If
- Experiencing prolonged cardiovascular effects
Frequently Asked Questions
Common questions about Kisspeptin
How long until I see effects?
Kisspeptin typically results in an LH surge within 2-5 hours after administration.
What time of day should I take it?
Kisspeptin is best taken in the morning to align with natural reproductive hormone rhythms.
How can I minimize side effects?
To minimize side effects, kisspeptin should be administered at the lowest effective dose under guidance, avoiding daily dosing.
Does tolerance develop?
Yes, kisspeptin can cause receptor desensitization if used daily, so avoid frequent dosing.
How should I store it?
Store kisspeptin in the refrigerator at 2-8°C and use reconstituted solutions within 7-14 days.
Do I need to cycle it?
Yes, cycling is recommended typically lasting 2-4 weeks with breaks to prevent receptor desensitization.
Reported Combinations
Compounds reported to be used alongside Kisspeptin in community discussions
GnRH
Synergistic effect on reproductive hormone release.
Testosterone
Compatible for enhanced results in reproductive therapy.
hCG
Alternative use in triggering ovulation in IVF treatments.
Reported Interactions
Interactions reported in literature and community discussions.
Should not be combined due to enhanced gonadal stimulation risk.
May enhance effects of estrogen; caution advised.
Potential increase in physiological effects; monitor closely.
Possible interaction by altering blood pressure effects.
May increase side effects like flushing.
Reconstitution Calculator
100 units = 1 mL
Safety Tips
- Always consult a licensed medical professional for dosing and reconstitution instructions.
- Always double check your units. Mixing up mg and mcg can be very dangerous.
- Make sure to select your syringe type. U-100 and U-50 syringes have different units.
- Ensure you're not adding more BAC than your vial can hold. Most vials have maximum capacities listed.
This calculator is for informational and educational purposes only. It does not provide medical advice, dosing recommendations, or safety determinations. Reference ranges shown are compiled from publicly available sources and are not a substitute for guidance from a licensed healthcare professional.
Legal Status by Region
Regulatory status varies by country
USA
investigational
UK
investigational
EU
investigational
Australia
investigational
Canada
investigational
Explore More Research
Browse our database of peptide research information compiled from published literature and community sources.
Citations
Last updated: October 2, 2023